Navigation Links
LaVoie Group Honored by LACP with Two Awards
Date:3/9/2010

League of American Communications Professionals Honors LaVoie Group for Best Industry-Exclusive Agency and Best Business Development Program for sanofi-aventis

Salem, MA (Vocus) March 9, 2010 -- LaVoie Group, a life science and pharmaceuticals focused strategic communications agency, announced today that it has won two 2009 Impact Awards from the League of American Communications Professionals (LACP), “Best Industry-Exclusive Agency” and “Best Business Development Communications Program.” These awards recognize LaVoie Group’s ability to provide senior level counsel and tactical implementation of corporate and product communications programs designed to properly position, create visibility with key target audiences and demonstrate creativity.

For the second straight year, LaVoie Group was honored as “Best Industry-Exclusive Agency” by the LACP. In the volatile economic climate of 2009, LaVoie Group was able to adapt to the changing market dynamics and leverage the agency’s breadth of experience across life sciences to win 10 new clients, including industry-leading pharmaceutical companies, such as Invida Pharmaceuticals and Pfizer. Through these clients, LaVoie Group was able to establish a pharmaceutical practice, which continues to grow in 2010. In addition, LaVoie guided the communications for ESBATech AG through one of the most successful M&A exits of 2009 in its sale to Alcon for up to $550 million.

Included in LaVoie Group’s pharmaceutical practice is sanofi-aventis, one of the world’s largest pharmaceutical companies, who in 2009 engaged LaVoie Group to execute a partnering event in its Cambridge, MA location. The agency’s suite of capabilities was fully leveraged to position the event with both the media and partners, as well as develop branded materials to support the company’s efforts to raise awareness in the area. LaVoie Group helped secure over 250 guests and the resulting media coverage appeared in the Boston Globe, Wall Street Journal, New York Times, Bloomberg, Reuters and XConomy. For these efforts, LACP honored LaVoie with the award for “Best Business Development Communications Program.”    

Christine Kennedy, LACP Managing Director commented, “This year’s entries, ‘LaVoie Group: Adapting, Changing, and Renewal in a Volatile Economic Climate,’ and ‘Sanofi-aventis Business Development Event’ prove to be remarkable in light of tremendous competition. More than 100 entries were received for the 2009 Impact Awards, comprising the best in communications from eight countries. We congratulate the entire team involved with this year’s entry, among the top 100 of 2009 as judged by the LACP this year.”

Donna L. LaVoie, President and Chief Executive Officer of LaVoie Group, said, “2009 was a challenging year throughout the industry, and our group’s ability to understand and adapt to market volatility allowed us to add value to our clients and demonstrate the necessity of strategic communications counsel. We’re especially proud of our work with sanofi-aventis on their partnering day, which brought together leading biotechnology players to learn how a partnership with this leading pharmaceutical company could add value to their clinical portfolios.”


About LACP
League of American Communications Professionals (LACP) was established in 2001 in order to create a forum within the public relations industry that facilitates discussion of best-in-class practices within the profession while also recognizing those who demonstrate exemplary communications capabilities. As part of this goal, LACP hosts a free monthly newsletter distributed via e-mail and quarterly competitions that target various disciplines within the communications field. Currently, more than 30,000 subscribers receive the monthly newsletter, which shares best practices; provides tools, tips, and resources to professionals; and hosts various forums to discuss industry trends and challenges. The quarterly competitions routinely include hundreds of entries from some of the most recognized organizations throughout the world. For more information, please visit http://www.lacp.com.

About LaVoie Group, Inc.
LaVoie Group provides senior-level counsel and tactical implementation of strategic communications programs designed to properly position, create visibility and drive value for each client. We help our life sciences and pharmaceutical clients attract capital, reach corporate partners, generate revenue and build their companies through integrated communications programs. Our clients range from privately held start-ups to industry leaders in life sciences such as Pfizer Inc., sanofi-aventis, Invida Pharmaceuticals, Vertex Pharmaceuticals, Rockwell Medical, Genetix Pharmaceuticals, Cardioxyl Pharmaceuticals and Profectus Biosciences. LaVoie Group is ranked by O’Dwyer’s PR Report as one of the leading independent healthcare PR firms in the U.S. For more information, please visit http://www.lavoiegroup.com.

Contact

Donna L. LaVoie   
President & CEO
LaVoie Group
978-745-4200

# # #

Read the full story at http://www.prweb.com/releases/LaVoie_group/LACP/prweb3701564.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster
2. LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record
3. Invida Selects LaVoie Group as Public Relations Agency of Record
4. Invida Selects LaVoie Group as Public Relations Agency of Record
5. Avicena Group to Present at Noble Financial Conference
6. Chrome Group to Seek Listing for Some of its Subsidiaries
7. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
8. Reed Group to Provide MDA Internet Disability Duration Guidelines to U.S. Navy
9. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
10. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
11. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
LaVoie Group Honored by LACP with Two Awards
(Date:12/8/2016)... Eurofins announces the appointment of Sean Murray , ... Inc. (ESI). Mr. Murray will bring valuable expertise ... experience in leading international business teams. As the National Division Leader, ... uphold Eurofins, status as the global leader in bio-analytical testing services. ... , , ...
(Date:12/8/2016)...  Anaconda BioMed S.L., a pre-clinical stage medical device ... neuro-thrombectomy system for the treatment of Acute Ischemic Stroke ... to join its Scientific Advisory Board (SAB). The SAB ... scientific and clinical experts to Anaconda BioMed S.L., as ... ® to its clinical phase. The SAB is ...
(Date:12/8/2016)... 8, 2016  Soligenix, Inc. (OTCQB: SNGX) (Soligenix ... on developing and commercializing products to treat rare ... announced today the long-term follow-up data from its ... first-in-class Innate Defense Regulator (IDR), in the treatment ... cancer patients undergoing chemoradiation therapy (CRT).  The additional ...
(Date:12/8/2016)... , Dec. 8, 2016  Partnering to fuel ... Ben Franklin Technology Partners of Southeastern Pennsylvania ... ("IHG"), the parent company of Independence Blue Cross; and ... announced their intentions for a $6 million funding initiative ... healthcare startups. Responding to a burgeoning economic ...
Breaking Biology Technology:
(Date:11/19/2016)... 2016 Securus Technologies, a leading provider of ... investigation, corrections and monitoring, announced today that it has ... have an independent technology judge determine who has the ... tech/sophisticated telephone calling platform, and the best customer service. ... most of what we do – which clearly is ...
(Date:11/15/2016)... 15, 2016  Synthetic Biologics, Inc. (NYSE MKT: ... on the gut microbiome, today announced the pricing ... of its common stock and warrants to purchase ... price to the public of $1.00 per share ... from the offering, excluding the proceeds, if any ...
(Date:6/27/2016)... Research and Markets has announced the addition ... to their offering. The report ... to grow at a CAGR of 12.28% during the period 2016-2020. ... in-depth market analysis with inputs from industry experts. The report covers ... The report also includes a discussion of the key vendors operating ...
Breaking Biology News(10 mins):